Section 232 Expansion Targets Pharmaceutical Imports
On April 2, 2026, the White House issued the proclamation, “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States,” formally extending Section 232 measures to certain patented pharmaceutical products and ingredients following a national security investigation. As part of this action, a 100% tariff will apply to covered patented pharmaceutical products and ingredients,…
Read More »